Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven I Blum

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Journal of Medical Economics|October 22, 2014
Economic evaluation of linaclotide for the treatment of adult patients with irritable bowel syndrome with constipation in the United StatesHuan Huang, Douglas C A Taylor, Robyn T Carson, et al.
Therapeutic Innovation & Regulatory Science|September 18, 2018
The Patient-Reported Outcome (PRO) Consortium: Lessons Learned Along the Path to PRO Instrument QualificationRisa P Hayes, Steven I Blum, Mark Forrest Gordon, et al.
Current Medical Research and Opinion|February 23, 2012
Persistence with nebivolol in the treatment of hypertension: a retrospective claims analysisJames E Signorovitch, Thomas M Samuelson, Karthik Ramakrishnan, et al.
Respiratory Medicine|August 3, 2011
Clinical and economic outcomes of multiple versus single long-acting inhalers in COPDAndrew P Yu, Annie Guérin, Diego Ponce de Leon, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 19, 2022
Comparing patient global impression of severity and patient global impression of change to evaluate test-retest reliability of depression, non-small cell lung cancer, and asthma measuresSonya Eremenco, Wen-Hung Chen, Steven I Blum, et al.
The Patient|June 27, 2015
Patient-Centered Research to Support the Development of the Symptoms of Major Depressive Disorder Scale (SMDDS): Initial Qualitative ResearchKelly P McCarrier, Linda S Deal, Lucy Abraham, et al.
Pain|June 12, 2018
Mixed-methods development of a new patient-reported outcome instrument for chronic low back pain: part 2-The Patient Assessment for Low Back Pain-Impacts (PAL-I)Donald M Bushnell, Steven I Blum, Hiltrud Liedgens, et al.
Pain Medicine (Malden, Mass.)|March 25, 2017
Assessment of Patient-Reported Outcome Instruments to Assess Chronic Low Back PainAbhilasha Ramasamy, Mona L Martin, Steven I Blum, et al.
The Lancet. Oncology|January 15, 2022
Patient-reported outcomes with first-line nivolumab plus cabozantinib versus sunitinib in patients with advanced renal cell carcinoma treated in CheckMate 9ER: an open-label, randomised, phase 3 trialDavid Cella, Robert J Motzer, Cristina Suarez, et al.
Future Oncology (London, England)|October 25, 2024
Plain language summary of quality of life in CheckMate 9ER: Cabozantinib plus nivolumab in advanced renal cell carcinomaDavid Cella, Robert J Motzer, Cristina Suarez, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Journal of Medical Economics|October 22, 2014
Economic evaluation of linaclotide for the treatment of adult patients with irritable bowel syndrome with constipation in the United StatesHuan Huang, Douglas C A Taylor, Robyn T Carson, et al.
Therapeutic Innovation & Regulatory Science|September 18, 2018
The Patient-Reported Outcome (PRO) Consortium: Lessons Learned Along the Path to PRO Instrument QualificationRisa P Hayes, Steven I Blum, Mark Forrest Gordon, et al.
Current Medical Research and Opinion|February 23, 2012
Persistence with nebivolol in the treatment of hypertension: a retrospective claims analysisJames E Signorovitch, Thomas M Samuelson, Karthik Ramakrishnan, et al.
Respiratory Medicine|August 3, 2011
Clinical and economic outcomes of multiple versus single long-acting inhalers in COPDAndrew P Yu, Annie Guérin, Diego Ponce de Leon, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 19, 2022
Comparing patient global impression of severity and patient global impression of change to evaluate test-retest reliability of depression, non-small cell lung cancer, and asthma measuresSonya Eremenco, Wen-Hung Chen, Steven I Blum, et al.
The Patient|June 27, 2015
Patient-Centered Research to Support the Development of the Symptoms of Major Depressive Disorder Scale (SMDDS): Initial Qualitative ResearchKelly P McCarrier, Linda S Deal, Lucy Abraham, et al.
Pain|June 12, 2018
Mixed-methods development of a new patient-reported outcome instrument for chronic low back pain: part 2-The Patient Assessment for Low Back Pain-Impacts (PAL-I)Donald M Bushnell, Steven I Blum, Hiltrud Liedgens, et al.
Pain Medicine (Malden, Mass.)|March 25, 2017
Assessment of Patient-Reported Outcome Instruments to Assess Chronic Low Back PainAbhilasha Ramasamy, Mona L Martin, Steven I Blum, et al.
The Lancet. Oncology|January 15, 2022
Patient-reported outcomes with first-line nivolumab plus cabozantinib versus sunitinib in patients with advanced renal cell carcinoma treated in CheckMate 9ER: an open-label, randomised, phase 3 trialDavid Cella, Robert J Motzer, Cristina Suarez, et al.
Future Oncology (London, England)|October 25, 2024
Plain language summary of quality of life in CheckMate 9ER: Cabozantinib plus nivolumab in advanced renal cell carcinomaDavid Cella, Robert J Motzer, Cristina Suarez, et al.
Pageof 3